Alignment Healthcare Cuts Full-Year Profit Outlook as Medical Costs Run Hot
ALHC sits 34% above its 52-week low of $6.01.
Summary
Alignment Healthcare beat on top line but missed on profitability in Q3 2026: revenue rose 36.7% year-over-year to $1,358.3 million on membership of about 301,200, up 31.2%, yet adjusted EBITDA fell 32.8% to $21.8 million and the company swung to a net loss of $8.1 million from net income of $3.7 million a year earlier. The medical benefits ratio climbed to 89.5%, up roughly 240 basis points, driven by higher appeals and disputes, catastrophic cases and skilled nursing costs. Management raised full-year membership and revenue guidance but lowered adjusted gross profit and adjusted EBITDA guidance, now at no less than $575 million and $100 million respectively, and guided Q4 adjusted EBITDA to no less than negative $28 million. The cut lands on top of an already rough stretch: shares hit a 52-week low in September after the Baird conference, and the October 8th disclosure that the California H3815 HMO contract fell to 3.5 stars for 2027 threatens future quality bonus revenue. CEO John Kao said the revised guidance assumes no benefit from the corrective actions underway, so execution over the next two quarters is the whole story.
At the time of this announcement, ALHC was trading at $8.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $6.01 to $25.12. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.